Stay updated on GSK2857916 & Pembrolizumab in RRMM Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page.

Latest updates to the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedRevision label in the history view updated from v3.6.2 to v3.6.3. This indicates a new site update for the record history interface without changing the underlying study data or how the page functions.SummaryDifference0.1%

- Check19 days agoChange DetectedA new revision entry v3.6.2 was added to the study record history, and the previous v3.6.0 entry was removed. This reflects an update to the page’s revision metadata rather than substantive study information.SummaryDifference0.1%

- Check34 days agoChange DetectedThe history now includes a note that the study is no longer looking for participants and adds the revision tag v3.6.0, while removing the previous revision v3.5.5.SummaryDifference0.3%

- Check41 days agoChange DetectedThe study history now shows Revision: v3.5.5 added and Revision: v3.5.4 removed, updating the page's version trail.SummaryDifference0.1%

- Check62 days agoChange DetectedThe history now includes Revision: v3.5.4, replacing Revision: v3.5.3; this indicates a small software update for ClinicalTrials.gov without altering study details.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page’s displayed software/interface revision updates from version v3.5.2 to v3.5.3, without changing the underlying study record content.SummaryDifference0.1%

Stay in the know with updates to GSK2857916 & Pembrolizumab in RRMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page.